NDC 68071-4375-05 - Neomycin Polymyxin B Sulfates and Dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-4375
- Requested NDC
- 68071-4375-05
- Package NDCs from labels
- 68071-4375-5, 68071-4375-05
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neomycin Polymyxin B Sulfates and Dexamethasone - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-06-15 | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, USP (Sterile) |
| 2023-01-30 | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, USP (Sterile) |
| 2021-02-16 | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, USP (Sterile) |
| 2021-01-29 | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, USP (Sterile) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4375-5 | Neomycin Polymyxin B Sulfates and Dexamethasone | 5 mL in 1 BOX | SUSPENSION/ DROPS | 5 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4375 | NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE) SUSPENSION/ DROPS [NUCARE PHARMACEUTICALS,INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20240608_691bc5ca-5d61-60c2-e053-2991aa0abb93.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Double Antibiotic | BACITRACIN ZINC AND POLYMYXIN B SULFATE | STRATUS PHARMACEUTICALS INC | f64b3564-ea3c-4316-8f00-f92c08dcad35 | 2026-02-04 | Warnings | 19371312D4 |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | Sportpharm LLC | 476b8c6d-44e2-47e3-a75c-b4328dfe82a1 | 2026-02-03 | Warnings, Adverse reactions | 19371312D4 |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Hand Wash | BENZALKONIUM CHLORIDE | Demoulas Super Markets, Inc | 3fe61130-9ec2-4e71-b147-320a81c4344c | 2026-02-03 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Escudo Ultra-Protect Original | BENZALKONIUM CHLORIDE | Indelpa, Inc | 1cd4c38f-8156-bd74-e063-6394a90a9f56 | 2026-02-03 | Warnings | F5UM2KM3W7 |
| Escudo Ultra-Protect Soft Care | BENZALKONIUM CHLORIDE | Indelpa, Inc. | 1cc4b68b-dceb-3fab-e063-6294a90ab112 | 2026-02-03 | Warnings | F5UM2KM3W7 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM | A-S Medication Solutions | aaa468d2-470f-43cf-b4e2-68aeb94a1e71 | 2026-02-03 | Warnings, Adverse reactions | 19371312D4 |
| WIPES4HEALTH | BENZALKONIUM CHLORIDE | Bubble Marketing LLC | 5d6dd15b-d087-4f25-bd2b-035ecacd5f97 | 2026-02-03 | Warnings | F5UM2KM3W7 |
| Foaming Hand | BENZALKONIUM CHLORIDE | Cintas Corporation | 17fb34e7-c9e6-41aa-991f-bb54c84ed79c | 2026-02-02 | Warnings, Adverse reactions | F5UM2KM3W7 |
| RELEEV Cold Sore Treatment | BENZALKONIUM CHLORIDE | Merix Pharmaceutical Corp. | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 2026-02-02 | Warnings | F5UM2KM3W7 |
| CLUB WIPES USA SANITIZING WIPES | BENZALKONIUM CHLORIDE | Bubble Marketing LLC | a0e4b04c-2227-49d2-8ccc-c7647b07cb02 | 2026-02-02 | Warnings | F5UM2KM3W7 |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Drs. pharmacy triple antibiotic plus lidocaine | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, LIDOCAINE OINTMENT | OL PHARMA TECH, LLC | 49a73b0f-90d9-3a4b-e063-6294a90acfb0 | 2026-01-30 | Warnings | 057Y626693 19371312D4 |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 451W47IQ8X |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 451W47IQ8X |
| TheraCare Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, AND PRAMIXINE HCL | Veridian Healthcare | d2374664-4668-4da5-9df7-44e6e421ad54 | 2026-01-29 | Warnings | 057Y626693 19371312D4 |
| CVS ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | CVS | 44821c47-63f9-5d0a-e063-6394a90a555d | 2026-01-29 | Warnings | 451W47IQ8X |
| Moisturizing Antibacterial | BENZALKONIUM CHLORIDE 0.13% | Aldi, LLC | bcde5681-5bc6-41a7-890e-27ba6f4e4be6 | 2026-01-29 | Warnings, Adverse reactions | F5UM2KM3W7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.